With the aim to authenticate and regulate medical information, Cancer Research UK plans to provide the most up-to-date and accurate healthcare information.
Cancer Research UK is calling for scientists, doctors and nurses to get more involved in Wikipedia to help ensure the free online encyclopaedia has the most up to date and accurate information on cancer.
Speaking at the Wikimania 2014 conference in London, Cancer Research UK will be discussing Wikipedia’s role as a resource for people searching for cancer-related information on the Internet, and how this fits in with their use of other online medical content.
The charity — working with Wikimedia UK – is employing an ‘in-house’ Wikipedian in Residence** and at the conference, will also its outline plans — as part of this project - to evaluate how people use the site to find information, and how to make its pages easier to understand.
It will also be evaluating whether the content has improved since the project began. A panel including Wikipedia’s medical editors will discuss the issues.
Original report: http://bit.ly/1usGwos
Source: Cancer Research UK
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Trastuzumab Deruxtecan Receives FDA Approval for HER2-Positive Solid Tumors
April 5th 2024FDA granted accelerated approval to trastuzumab deruxtecan-nxki for adult patients with unresectable or metastatic HER2-positive solid tumors who received prior systemic treatment and have no satisfactory alternative treatment options.
Read More